Future treatment of vascular calcification in chronic kidney disease

M Cozzolino, F Maffei Faccioli, A Cara… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Cardiovascular disease (CVD) is one of the global leading causes of morbidity
and mortality in chronic kidney disease (CKD) patients. Vascular calcification (VC) is a major …

Vascular calcification: Molecular mechanisms and therapeutic interventions

W Pan, W Jie, H Huang - MedComm, 2023 - Wiley Online Library
Vascular calcification (VC) is recognized as a pathological vascular disorder associated with
various diseases, such as atherosclerosis, hypertension, aortic valve stenosis, coronary …

Vascular calcification: an important understanding in nephrology

S Zununi Vahed, S Mostafavi… - Vascular health and …, 2020 - Taylor & Francis
Vascular calcification (VC) is a life-threatening state in chronic kidney disease (CKD). High
cardiovascular mortality and morbidity of CKD cases may root from medial VC promoted by …

Mechanism and therapy of vascular calcification

S Hara, K Yokoyama - Clinical Calcium, 2004 - europepmc.org
Vascular calcification is clinically important, because it predicts a higher risk of
cardiovascular event. Its pathogenesis involve atherosclerosis and regulated by mechanism …

[HTML][HTML] Effects of vitamin K supplementation on vascular calcification in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

C Geng, L Huang, L Pu, Y Feng - Frontiers in Nutrition, 2023 - frontiersin.org
Background There is conflicting data on the effect of vitamin K supplementation against
vascular calcification in chronic kidney disease (CKD). We aimed to summarize current …

Management of vascular calcification in patients with chronic kidney disease

Y Xin, Z Xiaoliang - Chinese Journal of Nephrology, Dialysis & …, 2021 - njcndt.com
Treatment for vascular calcification in chronic kidney disease was based on the correction of
deterioration in mineral homeostasis and abnormalities in circulating levels of hormones …

Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling

Z Su, P Zong, J Chen, S Yang, Y Shen… - Journal of cellular …, 2020 - Wiley Online Library
Vascular calcification is an important risk factor for the mortality and morbidity in chronic
kidney disease (CKD). Unfortunately, until now there is no certain medication targeting …

Consensus and controversy on research progress and clinical practice of vascular calcification

H Huang, AH Zhang, J Chen… - Sheng li xue bao:[Acta …, 2022 - europepmc.org
Vascular calcification is an active and complex pathological process regulated by several
factors. Vascular calcification is closely related to the incidence and mortality of the …

Tanshinone IIa attenuates vascular calcification through inhibition of NF-κB and β-catenin signaling pathways

H Zhong, DY Li, SY Wang, JY Chen… - Sheng li xue bao …, 2022 - europepmc.org
Tanshinone IIa is a key ingredient extracted from the traditional Chinese medicine Salvia
miltiorrhiza (Danshen), and is widely used to treat various cardiovascular diseases. Vascular …

MO740 EFFECT OF DIPHOSPHONATES FOR VASCULAR CALCIFICATION IN CHRONIC KIDNEY DISEASE: A META-ANALYSIS

C Yang, X Xie, J Xing, X Yang… - Nephrology Dialysis …, 2021 - academic.oup.com
Abstract Background and Aims Vascular calcification is an independent predict factor of
cardiovascular mortality and all-cause mortality in chronic kidney disease (CKD) patients …